PE Spronk

463 total citations
21 papers, 362 citations indexed

About

PE Spronk is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, PE Spronk has authored 21 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in PE Spronk's work include Systemic Lupus Erythematosus Research (7 papers), T-cell and B-cell Immunology (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). PE Spronk is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), T-cell and B-cell Immunology (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). PE Spronk collaborates with scholars based in Netherlands, United Kingdom and United States. PE Spronk's co-authors include P. C. Limburg, Cees G. M. Kallenberg, C. G. M. Kallenberg, Gerda Horst, Bernardina T.F. van der Gun, Minke G. Huitema, P. C. Limburg, Hendrika Bootsma, Jan Willem Cohen Tervaert and Arnoud C. Toornvliet and has published in prestigious journals such as Annals of the Rheumatic Diseases, Critical Care and Lara D. Veeken.

In The Last Decade

PE Spronk

20 papers receiving 345 citations

Peers

Countries citing papers authored by PE Spronk

Since Specialization

Citations

This map shows the geographic impact of PE Spronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PE Spronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PE Spronk more than expected).

Fields of papers citing papers by PE Spronk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PE Spronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PE Spronk. The network helps show where PE Spronk may publish in the future.

Co-authorship network of co-authors of PE Spronk

This figure shows the co-authorship network connecting the top 25 collaborators of PE Spronk. A scholar is included among the top collaborators of PE Spronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PE Spronk. PE Spronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recovery of health-related quality of life in ICU patients: a 5-year prospective cohort study 2015 ·Critical Care ·José G.M. Hofhuis, Henk F. van Stel, (unknown), J. H. Rommes, PE Spronk	3
2	Vancomycin-resistant enterococci: eradication using vancomycin? 2014 ·Critical Care ·Joffrey van Prehn, (unknown), (unknown), PE Spronk	3
3	Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial 2011 ·Critical Care ·(unknown), (unknown), (unknown), Michaël Kuiper, (unknown), Mathieu van der Jagt, PE Spronk, Willem A. van Gool, (unknown), Jozef Kesecioğlu, (unknown)	27
4	Blood glucose variability, measured as mean absolute glucose, strongly depends on the frequency of blood glucose level measurements 2011 ·Critical Care ·(unknown), (unknown), PE Spronk, MJ Schultz, Ameen Abu‐Hanna	4
5	Infectious pleural effusions can be identified by sTREM-1 levels 2009 ·Respiratory Medicine ·(unknown), Ahmed Achouiti, Ali A. El Solh, Paul Bresser, (unknown), PE Spronk, MJ Schultz	8
6	Low-dose nitroglycerin improves microcirculation in hospitalized patients with acute heart failure 2009 ·Critical Care ·(unknown), (unknown), PE Spronk, (unknown), Lucia S.D. Jewbali, (unknown), Can İnce, Simoons Ml	3
7	Validation of the dutch version of the Confusion Assessment Method (CAM-ICU) for delirium screening in the Intensive Care Unit 2009 ·Ralph Vreeswijk, Arnoud C. Toornvliet, K. Bakker, PE Spronk, (unknown), (unknown)	21
8	Intensive insulin therapy: protocols in use in The Netherlands 2008 ·Critical Care ·(unknown), Hans Kieft, (unknown), (unknown), (unknown), PE Spronk, MJ Schultz	2
9	Consumption of ICU resources by long-stay patients does not change over time: 10-year observation in a teaching hospital in The Netherlands 2008 ·Critical Care ·Annelot F. Schoffelen, J Hofhuis, J. H. Rommes, PE Spronk	4
10	Relationship between the sublingual microcirculation and lactate levels in patients with heart failure 2008 ·Critical Care ·(unknown), (unknown), Eva Klijn, Can İnce, PE Spronk, Simoons Ml	1
11	Reply to Letter to the Editor “Diagnosis and treatement of brucellosis” 2000 ·The Netherlands Journal of Medicine ·PE Spronk	1
12	Regional Specific Changes of Cerebral Metabolism in Systemic Lupus erythematosus Identified by Positron Emission Tomography 1999 ·European Neurology ·Bauke M. de Jong, J. Pruim, L. G. F. Sinnige, (unknown), PE Spronk, Hendrika Bootsma, Cees G. M. Kallenberg, (unknown), Hanny Haaxma-Reiche	8
13	Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus? 1998 ·Journal of Autoimmunity ·Marc Bijl, (unknown), P. C. Limburg, PE Spronk, Sonja M.H.J. Jaegers, L Aarden, R J Smeenk, (unknown)	26
14	Usefulness of the SLICC/ACR damage index in patients with systemic lupus erythematosus. 1997 ·Data Archiving and Networked Services (DANS) ·Hendrika Bootsma, R. H. W. M. Derksen, (unknown), PE Spronk, Marc Bijl, L Kater, Cornelis Kallenberg	7
15	ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS 1996 ·Lara D. Veeken ·PE Spronk, Hendrika Bootsma, Gerda Horst, Minke G. Huitema, P. C. Limburg, Jan Willem Cohen Tervaert, Cees G. M. Kallenberg	52
16	LEVELS OF SOLUBLE ADHESION MOLECULES DURING DISEASE RELAPSES OF SYSTEMIC LUPUS-ERYTHEMATOSUS - A LONG-TERM PROSPECTIVE-STUDY 1994 ·Data Archiving and Networked Services (DANS) ·PE Spronk, Hendrika Bootsma, Minke G. Huitema, (unknown), Cornelis Kallenberg	2
17	Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. 1994 ·Annals of the Rheumatic Diseases ·PE Spronk, E. J. ter Borg, Minke G. Huitema, P. C. Limburg, C. G. M. Kallenberg	16
18	B-CELL ACTIVATION CORRELATES WITH IG-LEVELS BUT NOT WITH ANTI-DSDNA IN NON-ACTIVE SLE, AND INCREASES PARALLEL TO ANTI-DSDNA PRIOR TO DISEASE-ACTIVITY 1993 ·Data Archiving and Networked Services (DANS) ·PE Spronk, (unknown), Gerda Horst, P. C. Limburg, (unknown)	1
19	B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation 1993 ·Clinical & Experimental Immunology ·PE Spronk, (unknown), P. C. Limburg, Cees G. M. Kallenberg	23
20	Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? 1992 ·Clinical & Experimental Immunology ·PE Spronk, (unknown), P. C. Limburg, C. G. M. Kallenberg	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact